Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × NIH × Lupus Nephritis × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 49 Breast Neoplasms 46 Neoplasms 38 Leukemia, Lymphocytic, Chronic, B-Cell 37 Carcinoma, Non-Small-Cell Lung 36 Neoplasm Metastasis 29 Lymphoma, Large B-Cell, Diffuse 25 Precursor Cell Lymphoblastic Leukemia-Lymphoma 24 Brain Neoplasms 24 Lymphoma, Follicular 23 Colonic Neoplasms 22 Carcinoma, Renal Cell 22 Rectal Neoplasms 21 Lymphoma, Non-Hodgkin 21 Lung Neoplasms 21 Prostatic Neoplasms 20 Glioblastoma 20 Leukemia, Myeloid, Acute 19 Kidney Neoplasms 19 Lymphoma, B-Cell, Marginal Zone 18 Pancreatic Neoplasms 17 Lymphoma, Mantle-Cell 17 Gliosarcoma 17 Burkitt Lymphoma 17 Sarcoma 16 Multiple Myeloma 16 Waldenstrom Macroglobulinemia 15 Ovarian Neoplasms 15 Esophageal Neoplasms 15 Lymphoma 14

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00447265 2013-02-12

Etanercept for the Treatment of Lupus Nephritis

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 2 Terminated

1 enrolled 15 charts

Lupus Nephritis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡